128 related articles for article (PubMed ID: 24875077)
1. A double-blind, placebo-controlled trial of dextromethorphan combined with clonidine in the treatment of heroin withdrawal.
Lin SK; Pan CH; Chen CH
J Clin Psychopharmacol; 2014 Aug; 34(4):508-12. PubMed ID: 24875077
[TBL] [Abstract][Full Text] [Related]
2. Lack of efficacy of dextromethorphan in managing alcohol withdrawal: a preliminary report of a randomized, double-blind, placebo-controlled trial.
Huang MC; Chen CH; Pan CH; Lin SK
J Clin Psychopharmacol; 2014 Feb; 34(1):149-52. PubMed ID: 24346753
[TBL] [Abstract][Full Text] [Related]
3. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
Collins ED; Kleber HD; Whittington RA; Heitler NE
JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
[TBL] [Abstract][Full Text] [Related]
4. Dextromethorphan and quinidine combination for heroin detoxification.
Akerele E; Bisaga A; Sullivan MA; Garawi F; Comer SD; Thomas AA; Nunes EV; Kleber HD
Am J Addict; 2008; 17(3):176-80. PubMed ID: 18463993
[TBL] [Abstract][Full Text] [Related]
5. Venlafaxine for acute heroin detoxification: a double-blind, randomized, control trial.
Lin SK; Chen CH; Pan CH
J Clin Psychopharmacol; 2008 Apr; 28(2):189-94. PubMed ID: 18344729
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
[TBL] [Abstract][Full Text] [Related]
7. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
[TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled trial of dextromethorphan as an adjunct in opioid-dependent patients undergoing methadone maintenance treatment.
Lee SY; Chen SL; Chang YH; Chu CH; Chen SH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv008. PubMed ID: 25716777
[TBL] [Abstract][Full Text] [Related]
9. Use of qigong therapy in the detoxification of heroin addicts.
Li M; Chen K; Mo Z
Altern Ther Health Med; 2002; 8(1):50-4, 56-9. PubMed ID: 11795622
[TBL] [Abstract][Full Text] [Related]
10. Tetrodotoxin alleviates acute heroin withdrawal syndrome: a multicentre, randomized, double-blind, placebo-controlled study.
Song H; Li J; Lu CL; Kang L; Xie L; Zhang YY; Zhou XB; Zhong S
Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):510-4. PubMed ID: 21575032
[TBL] [Abstract][Full Text] [Related]
11. A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal.
Yu E; Miotto K; Akerele E; Montgomery A; Elkashef A; Walsh R; Montoya I; Fischman MW; Collins J; McSherry F; Boardman K; Davies DK; O'Brien CP; Ling W; Kleber H; Herman BH
Drug Alcohol Depend; 2008 Sep; 97(1-2):158-68. PubMed ID: 18508207
[TBL] [Abstract][Full Text] [Related]
12. Scopolamine detoxification technique for heroin dependence: a randomized trial.
Liu S; Li L; Shen W; Shen X; Yang G; Zhou W
CNS Drugs; 2013 Dec; 27(12):1093-102. PubMed ID: 24092568
[TBL] [Abstract][Full Text] [Related]
13. [A randomized, double-blind, controlled study: Ji-Tai tablet for the treatment of acute withdrawl syndrome of mild heroin dependence].
Wang Y; Tang C; Cheng S; Cui G; Zhang R; Zhang Z; Xie L; Lin Y; Hao W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Feb; 40(2):117-22. PubMed ID: 25769319
[TBL] [Abstract][Full Text] [Related]
14. Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial.
Akhondzadeh S; Kashani L; Mobaseri M; Hosseini SH; Nikzad S; Khani M
J Clin Pharm Ther; 2001 Oct; 26(5):369-73. PubMed ID: 11679027
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Adding Memantine to Clonidine in Reducing Withdrawal Symptoms in Opioid-Dependent Patients: A Double-Blind Randomized Controlled Trial.
Kheirabadi G; Najafian N; Khodadadi F
J Clin Psychopharmacol; 2021 Nov-Dec 01; 41(6):644-649. PubMed ID: 34559090
[TBL] [Abstract][Full Text] [Related]
16. Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal.
Lin SK; Strang J; Su LW; Tsai CJ; Hu WH
Drug Alcohol Depend; 1997 Nov; 48(2):127-33. PubMed ID: 9363412
[TBL] [Abstract][Full Text] [Related]
17. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
Day E; Strang J
J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
[TBL] [Abstract][Full Text] [Related]
18. Lofexidine versus diazepam for the treatment of opioid withdrawal syndrome: A double-blind randomized clinical trial in Singapore.
Guo S; Manning V; Yang Y; Koh PK; Chan E; de Souza NN; Assam PN; Sultana R; Wijesinghe R; Pangjaya J; Kandasami G; Cheok C; Lee KM; Wong KE
J Subst Abuse Treat; 2018 Aug; 91():1-11. PubMed ID: 29910009
[TBL] [Abstract][Full Text] [Related]
19. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids.
Cheskin LJ; Fudala PJ; Johnson RE
Drug Alcohol Depend; 1994 Oct; 36(2):115-21. PubMed ID: 7851278
[TBL] [Abstract][Full Text] [Related]
20. Tai-Kang-Ning, a Chinese herbal medicine formula, alleviates acute heroin withdrawal.
Kang L; Li B; Gao L; Li S; Wang D; Hu M; Li J
Am J Drug Alcohol Abuse; 2008; 34(3):269-76. PubMed ID: 18428069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
